|
2024
|
Invention
|
Compound and pharmaceutical composition comprising same. The present invention provides: a novel ... |
|
|
Invention
|
Pyrazolopyrimidine derivative as cyclin-dependent kinase 9 inhibitor. The novel pyrazolopyrimidin... |
|
2022
|
Invention
|
Pharmaceutical composition for preventing or treating tumor, and use thereof.
According to an as... |
|
|
Invention
|
Pharmaceutical composition for preventing or treating tumor, and use thereof. According to an asp... |
|
|
Invention
|
Galactoside derivative as galectin-3 inhibitor.
A galactoside compound of Formula (I) is disclos... |
|
|
Invention
|
Galactoside derivative as galectin-3 inhibitor. A galactoside derivative according to the present... |
|
2019
|
Invention
|
Salt and crystalline form of furopyrimidine compound and pharmaceutical use thereof. Salts and cr... |
|
2016
|
Invention
|
Fusion protein having factor vii activity. A fusion protein comprising factor VII (FVII) and tran... |
|
2014
|
Invention
|
Pharmaceutical composition with improved stability containing factor vii fusion protein. The pres... |
|
|
Invention
|
Tricyclic compound and use thereof. The present invention relates to: a compound selected from th... |
|
|
Invention
|
Method of isolating and purifying fusion protein comprising factor vii.
The present invention pr... |
|
2013
|
Invention
|
Gonadotropin releasing hormone receptor antagonists, method for the preparation thereof and pharm... |
|
2012
|
Invention
|
2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors. The present invention provides a... |
|
2011
|
Invention
|
Fusion protein having factor ix activity. Disclosed is a fusion protein comprising blood coagulat... |
|
2010
|
Invention
|
Gonadotropin releasing hormone receptor antagonist, preparation method thereof and pharmaceutical... |
|
2009
|
Invention
|
2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors. 2-pyridyl substituted imidazoles... |
